Kok et al. assessed the effectiveness of administering a single intraoperative dose of intravenous dexamethasone, a glucocorticoid receptor agonist, on depression and post-traumatic stress disorder (PTSD) following cardiac surgery (172). This evidence concerns the gene NR3C1 and depressive symptom measurement.